P. Greenberg
Immunology · Cell · 2004–2022
A researcher in the Science corpus: 7 papers; trusts 15 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 143 citations into it; #524 of 2,160 by trust here, #745 by citations
- Oncology — 99 citations into it
Whom P. Greenberg trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- E. Wherry
- Ronald H. Schwartz
- J. Wherry
- M. Keir
- Rafi Ahmed
- Daniel L. Barber
- S. Topalian
- F. Hodi
- F. Quintana
Who trusts P. Greenberg overall
Papers from P. Greenberg's perspective
Ordered by how strongly the researchers P. Greenberg trusts endorse each paper. Same corpus, a different order for every researcher.
- Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
- Memory CD8 T-Cell Differentiation during Viral Infection (Journal of Virology)
- PD-1 and its ligands in tolerance and immunity. (Annual Review of Immunology)
- Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens (Nature)
- T cell exhaustion (Nature Immunology)
- PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients (Journal of Experimental Medicine)
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
- Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade (Nature)
- Persistent LCMV infection is controlled by blockade of type 1 interferon signaling (Science)
Their papers
- Multiple early factors anticipate post-acute COVID-19 sequelae (2022) — 994 citations
- Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies (2017) — 617 citations
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis (2016) — 623 citations
- Tolerance and Exhaustion: Defining Mechanisms of T cell Dysfunction (2013) — 633 citations
- Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. (2008) — 727 citations
- Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. (2006) — 841 citations
- Cancer Immunotherapy: A Treatment for the Masses (2004) — 645 citations